Redirecting to original paper in 30 seconds...
Click below to go immediately or wait for automatic redirect
📄 Abstract
Abstract: Accurately predicting the three-dimensional structures of protein-ligand
complexes remains a fundamental challenge in computational drug discovery that
limits the pace and success of therapeutic design. Deep learning methods have
recently shown strong potential as structural prediction tools, achieving
promising accuracy across diverse biomolecular systems. However, their
performance and utility are constrained by scarce experimental data,
inefficient architectures, physically invalid poses, and the limited ability to
exploit auxiliary information available at inference. To address these issues,
we introduce Pearl (Placing Every Atom in the Right Location), a foundation
model for protein-ligand cofolding at scale. Pearl addresses these challenges
with three key innovations: (1) training recipes that include large-scale
synthetic data to overcome data scarcity; (2) architectures that incorporate an
SO(3)-equivariant diffusion module to inherently respect 3D rotational
symmetries, improving generalization and sample efficiency, and (3)
controllable inference, including a generalized multi-chain templating system
supporting both protein and non-polymeric components as well as dual
unconditional/conditional modes. Pearl establishes a new state-of-the-art
performance in protein-ligand cofolding. On the key metric of generating
accurate (RMSD < 2 \r{A}) and physically valid poses, Pearl surpasses AlphaFold
3 and other open source baselines on the public Runs N' Poses and PoseBusters
benchmarks, delivering 14.5% and 14.2% improvements, respectively, over the
next best model. In the pocket-conditional cofolding regime, Pearl delivers
$3.6\times$ improvement on a proprietary set of challenging, real-world drug
targets at the more rigorous RMSD < 1 \r{A} threshold. Finally, we demonstrate
that model performance correlates directly with synthetic dataset size used in
training.
Authors (40)
Genesis Research Team
Alejandro Dobles
Nina Jovic
Kenneth Leidal
Pranav Murugan
David C. Williams
+34 more
Submitted
October 28, 2025
Key Contributions
Introduces Pearl, a foundation model for protein-ligand cofolding that addresses key challenges in structure prediction. It utilizes large-scale synthetic data, SO(3)-equivariant diffusion modules for inherent 3D symmetry, and improved architectures to predict accurate and physically valid protein-ligand complex structures at scale.
Business Value
Significantly accelerates the drug discovery pipeline by enabling faster and more accurate prediction of how drug candidates bind to target proteins. Reduces R&D costs and time-to-market for new therapeutics.